Abstract
Despite the introduction of drug-eluting stents restenosis remains an important clinical problem. In this review we examine the role of plasminogen activator inhibitor-1 (PAI-1) in controlling restenosis after balloon angioplasty and stent implantation.
Keywords: Urokinase, vascular wall, restenosis, carotid artery ligation, VSMC proliferation
Current Drug Targets
Title: Plasminogen Activator Inhibitor-1 and Restenosis
Volume: 8 Issue: 9
Author(s): Nadish Garg and William P. Fay
Affiliation:
Keywords: Urokinase, vascular wall, restenosis, carotid artery ligation, VSMC proliferation
Abstract: Despite the introduction of drug-eluting stents restenosis remains an important clinical problem. In this review we examine the role of plasminogen activator inhibitor-1 (PAI-1) in controlling restenosis after balloon angioplasty and stent implantation.
Export Options
About this article
Cite this article as:
Garg Nadish and Fay P. William, Plasminogen Activator Inhibitor-1 and Restenosis, Current Drug Targets 2007; 8 (9) . https://dx.doi.org/10.2174/138945007781662355
DOI https://dx.doi.org/10.2174/138945007781662355 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Maternal Sepsis 2010: Early Recognition and Aggressive Treatment with Early Goal Directed Therapy can Improve Maternal Outcomes
Current Women`s Health Reviews Glucagon and Glucagon-Like Peptide Receptors as Drug Targets
Current Pharmaceutical Design Bacterial Protein Toxins: Current and Potential Clinical Use
Current Medicinal Chemistry Structure-based Design on Anticancer Drug Discovery
Current Topics in Medicinal Chemistry Stroke as a Consequence of Sleep Apnea: Epidemiology, Pathophysiology and Treatment Strategies
Current Respiratory Medicine Reviews Effects of Lipid-Lowering Drugs on Adiponectin
Current Vascular Pharmacology Evaluation of Eudragit® Retard Polymers for the Microencapsulation of Alpha-Lipoic Acid
Current Drug Delivery Pregnancy in Type 2 Diabetes Mellitus - Problems & Promises
Current Diabetes Reviews Vitamin, Mineral, and Drug Absorption Following Bariatric Surgery
Current Drug Metabolism Persistent Clinical Response of Infliximab Therapy in Patients with Refractory Rheumatoid Arthritis, over a 3-Year Period
Current Clinical Pharmacology A More Accurate Approach to Molecular Genetics Analysis in Vascular Disease
Cardiovascular & Hematological Disorders-Drug Targets The Ignored Role of Intraoperative Hypotension in Producing Postoperative Acute Kidney Injury-An Obligatory Appeal for More Preventative Nephrology
Current Hypertension Reviews Hypertension in Polycystic Ovary Syndrome: Novel Insights
Current Hypertension Reviews Antiplatelet Therapy in Atherothrombotic Cardiovascular Diseases for Primary and Secondary Prevention: A Focus on Old and New Antiplatelet Agents
Current Pharmaceutical Design Colchicine: An Old Wine in a New Bottle?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Executive Function and Diabetes Mellitus - A Stone Left Unturned?
Current Diabetes Reviews Animal Models for Studying Neointima Formation
Current Vascular Pharmacology Potential Application of Induced Pluripotent Stem Cells in Cell Replacement Therapy for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Oxidative Stress and Mitochondrial Dysfunction in Sepsis: A Potential Therapy with Mitochondria-Targeted Antioxidants
Infectious Disorders - Drug Targets Regulation of the Cellular and Physiological Effects of Glutamine
Mini-Reviews in Medicinal Chemistry